SEC Sets Sights On Bristol-Myers In Foreign Bribery Crackdown
The subpoena, issued in March, relates to Bristol-Myers' sales and marketing practices in various countries, the pharmaceutical giant said in a regulatory filing with the SEC.
“The company is cooperating with the government in its investigation of these matters,” the filing said.
A company spokeswoman declined to comment further.
Bristol-Myers had disclosed in 2006 that the...
To view the full article, register now.